共 287 条
[1]
Singh S(2012)Drug safety assessment in clinical trials: methodological challenges and opportunities Trials 13 138-78
[2]
Loke YK(2017)Surrogate endpoints in oncology: when are they acceptable for regulatory and clinical decisions, and are they currently overused? BMC Med 15 134-1039
[3]
Kemp R(2000)Debate: the slippery slope of surrogate outcomes Curr Control Trials Cardiovasc Med 1 76-1016
[4]
Prasad V(2017)Good practices for real-world data studies of treatment and/or comparative effectiveness: recommendations from the joint ISPOR-ISPE special task force on real-world evidence in health care decision making Pharmacoepidemiol Drug Saf 26 1033-93
[5]
D’Agostino RB(2015)Identifying health outcomes in healthcare databases Pharmacoepidemiol Drug Saf 24 1009-1015
[6]
Berger ML(2012)Chapter 13: mining electronic health Records in the Genomics era PLoS Comput Biol 8 e1002823-627
[7]
Sox H(2016)A framework to support the sharing and reuse of computable phenotype definitions across health care delivery and clinical research applications eGEMs 4 1232-1318
[8]
Willke RJ(2016)Big data and its role in health economics and outcomes research: a collection of perspectives on data sources, measurement, and analysis PharmacoEconomics 34 91-245
[9]
Brixner DL(2016)Extracting information from the text of electronic medical records to improve case detection: a systematic review J Am Med Inform Assoc 23 1007-90
[10]
Eichler HG(2017)Classification of breast cancer histology images using convolutional neural networks PLoS One 12 e0177544-243